The professor opened up new possibilities for treating the disease with his groundbreaking work developing gold nanoparticles for targeted cancer therapy.

According to a study by Stanford University, a professor at Qatar University is among the top 2% of all accredited scientists worldwide.

Dr. Alaaldin M. Alkilany, a professor at the College of Pharmacy with a focus on pharmaceutical and nanoscience, was recognised for his outstanding achievements to the field of pharmaceutical sciences.

In both the US and Europe, Alkilany has successfully registered more than 20 medicinal items. In addition to advancing QU’s research ambitions since 2020, Alkilany has also advanced nanotechnology and pharmaceutical innovation on a global scale.

In particular, his groundbreaking work in the creation of gold nanoparticles for targeted cancer therapy has opened up new possibilities.

Recommended

Weekend Watchlist: 6 Things To Do This Weekend in Doha!Qatar Will Host The FIFA U-17 World Cup 2025!Ed Sheeran Is Coming To Abu Dhabi!

Alkilany concentrated on developing procedures for making gold nanoparticles with pinpoint accuracy for use in cancer treatment. Due to their unique optical characteristics, these nanoparticles may absorb external laser beams and transform them into localised heat.

It would then eliminate cancer cells by thermal ablation.

Additionally, he developed simple chemical techniques to extract complex nanoparticles for biomedical purposes from a mixture of medicinal polymers (PLGA), gold, and silver nanoparticles.

Through his partnership with Qatari pharmaceutical producer QLife Pharma, Alkilany’s study has taken on new meaning.